International Biotechnology Trust’s Jazz Pharmaceuticals JAZZ Stock Holding History

International Biotechnology Trust’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$2.23M	Hold	17,200	–	–	0.75%	38
2023 Q2	$2.13M	Hold	17,200	–	–	0.65%	37
2023 Q1	$2.51M	Hold	17,200	–	–	0.7%	36
2022 Q4	$2.74M	Hold	17,200	–	–	0.85%	30
2022 Q3	$2.29M	Buy	17,200 +14,517	+541%	+$2.21M	0.73%	39
2022 Q2	$17.2K	Sell	2,683 -14,517	-84%	-$2.23M	0.18%	67
2022 Q1	$5.92M	Sell	17,200 -27,000	-61%	-$3.92M	1.34%	25
2021 Q4	$5.63M	Hold	44,200	–	–	1.25%	27
2021 Q3	$5.75M	Buy	44,200 +24,200	+121%	+$3.66M	1.39%	24
2021 Q2	$3.55M	Buy	+20,000	New	+$3.46M	0.94%	28
2018 Q4	–	Sell	-21,600	Closed	-$2.79M	–	47
2018 Q3	$2.79M	Buy	21,600 +5,400	+33%	+$929K	1.32%	26
2018 Q2	$2.79M	Sell	16,200 -2,800	-15%	-$458K	1.07%	32
2018 Q1	$2.87M	Buy	+19,000	New	+$2.79M	1.12%	25
2017 Q3	–	Sell	-27,000	Closed	-$4.2M	–	58
2017 Q2	$4.2M	Hold	27,000	–	–	1.6%	20
2017 Q1	$3.92M	Buy	27,000 +8,800	+48%	+$1.15M	1.5%	20
2016 Q4	$1.98M	Buy	+18,200	New	+$2.03M	0.89%	25

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

International Biotechnology Trust's JAZZ Position: Q3 2023 in Review

International Biotechnology Trust held its Jazz Pharmaceuticals (JAZZ) position steady in Q3 2023 at 17,200 shares worth $2.23M. The position accounts for 0.75% of the portfolio, ranked #38.

International Biotechnology Trust first reported a position in JAZZ in Q4 2016 and has held it in 16 quarters since. The position peaked at $5.92M in Q1 2022. 484 funds tracked by Wall St. Rank hold JAZZ as of Q3 2023.

International Biotechnology Trust held 17,200 shares of Jazz Pharmaceuticals worth $2.23M as of Q3 2023.
International Biotechnology Trust left its Jazz Pharmaceuticals share count unchanged in Q3 2023.
Jazz Pharmaceuticals made up 0.75% of International Biotechnology Trust's portfolio in Q3 2023, its #38 holding.
International Biotechnology Trust first reported a position in Jazz Pharmaceuticals in Q4 2016 and has held it in 16 quarters since.
International Biotechnology Trust's Jazz Pharmaceuticals position peaked at $5.92M in Q1 2022.
484 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.